Literature DB >> 1595597

Lobular capillary hemangioma. An immunohistochemical study including steroid hormone receptor status.

G E Nichols1, M J Gaffey, S E Mills, L M Weiss.   

Abstract

Twenty-one lobular capillary hemangiomas (LCH), including lesions from six pregnant patients, were examined by immunohistochemical analysis. Antibodies to estrogen and progesterone receptor proteins were used to determine whether these steroid hormones play a direct role in LCH development and growth. All 21 LCHs were negative for both receptor proteins. Contrary to the association of LCH with pregnancy and oral contraceptive use, the absence of these steroid receptors strongly suggests that estrogen or progesterone are not directly involved in the formation of these lesions. All 21 LCHs were stained with Ulex europaeus lectin and with a panel of antibodies directed against cytokeratin, vimentin, Factor VIII, collagen Type IV, and muscle-specific actin. Endothelial cells in LCH, both in cellular proliferations with poorly formed lumens and in well-formed capillaries, were labeled by Factor VIII, Ulex europaeus lectin, and vimentin. A population of concentrically arranged, perivascular spindle-shaped cells was highlighted by positive staining for muscle-specific actin, collagen Type IV, and vimentin. The spindled cells were associated with both well-developed and immature vessels in all lesions. The appearance, immunophenotype, and location of these cells is consistent with a pericytic origin. Although the intimate association of both endothelial cells and pericytes suggests a reactive, as opposed to neoplastic, origin, other benign vascular tumors traditionally considered neoplastic have a similar bicellular composition. Accordingly, the findings neither support nor refute a neoplastic origin for LCH.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1595597     DOI: 10.1093/ajcp/97.6.770

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  8 in total

1.  Effective Management of a pregnancy tumour using a soft tissue diode laser: a case Report.

Authors:  Ambika Sharma; Vijay Prakash Mathur; Divesh Sardana
Journal:  Laser Ther       Date:  2014-12-27

2.  Intracranial capillary hemangioma: extra-axial tumorous lesions closely mimicking meningioma.

Authors:  Ji Hoon Phi; Seung-Ki Kim; Anna Cho; Dong Gyu Kim; Sun Ha Paek; Sung-Hye Park; Kyu-Chang Wang
Journal:  J Neurooncol       Date:  2012-04-29       Impact factor: 4.130

3.  Cellular markers that distinguish the phases of hemangioma during infancy and childhood.

Authors:  K Takahashi; J B Mulliken; H P Kozakewich; R A Rogers; J Folkman; R A Ezekowitz
Journal:  J Clin Invest       Date:  1994-06       Impact factor: 14.808

4.  Intravenous Lobular Capillary Hemangioma Occurring after Needle Insertion during Routine Health Checkup.

Authors:  Shinichi Taguchi; Toshihiro Kakefuda; Shigeshi Ono; Shinsaku Matsuda; Atsuo Mori; Yoshiaki Narimatsu; Ichiro Hasegawa; Hiroaki Sato; Jitsuro Tsukada; Hitoshi Sugiura; Rie Irie
Journal:  Ann Vasc Dis       Date:  2013-02-28

5.  A tentorial venous hemangioma presenting as an extra-axial mass in the ambient cistern: a case report.

Authors:  Soichi Oya; Richard A Prayson; Joung H Lee
Journal:  J Neurol Surg Rep       Date:  2012-05-17

6.  Vulvar pyogenic granuloma in a postmenopausal woman: case report and review of the literature.

Authors:  Deniz Cemgil Arikan; Gurkan Kiran; Hamide Sayar; Bulent Kostu; Ayhan Coskun; Hakan Kiran
Journal:  Case Rep Med       Date:  2011-09-08

7.  Pediatric intranasal lobular capillary hemangioma: Report of two new cases and review of the literature.

Authors:  Franklin Mariño-Sánchez; Mauricio Lopez-Chacon; Cristina Jou; Oliver Haag
Journal:  Respir Med Case Rep       Date:  2016-03-31

8.  Simultaneous occurrence of pyogenic granuloma at multiple sites associated with bone loss: Report of a rare case.

Authors:  Gatha Mohanty; Rinkee Mohanty; Anurag Satpathy
Journal:  J Indian Soc Periodontol       Date:  2018 Mar-Apr
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.